ZURICH, June 26 (Reuters) - The United States could open a trade investigation into Switzerland's pharmaceutical industry ...

The US may open a trade investigation into Switzerland's pharmaceutical industry, threatening tariffs on $35.5 billion in ...

Patient access to new medicines is worsening across Europe, the region's main pharmaceuticals industry lobby group said ​as ...

Companies see a commercial opportunity in creating new ways to administer drugs to patients – in space.

Three major pharmaceutical industry groups—two in the US and one in India—have called for changes to the US Food and Drug Administration's (FDA) Scale-Up and Post-Approval Changes (SUPAC) guidelines.

Washington has spared India’s generics from its new drug tariffs. But the real exposure running through India’s pharmacy lies ...

Europe will need to rethink how it values and pays for innovative medicines or risk losing manufacturing investments and ...

Industry body reaches out to members for information on ifosfamide manufacturing capacity amid shortage in the United States ...

For years, pure-play pharma product campaigns took the top plaudits but, since the COVID pandemic in 2020, there has been a notable shift. In the post-pandemic years, pharma took a backseat to medical ...

"Do we want our prescription refills to be approved or denied by Chinese Communist Party-controlled pharmaceutical companies?

In Guzzardi’s view, it wasn’t a coincidence that the three no-shows accepted more campaign contributions from the drug industry than most other state lawmakers nationwide: Between $6,000 and $15,000 ...